Oct 22, 2025
Oct 22, 2025
Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executive Officer
Oct 6, 2025
AtaCor Medical Secures $75M Financing to Support the Pivotal U.S. Study of its Extravascular ICD (EV-ICD) System
Sep 4, 2025
Edwards buys remaining stake of Vectorious Medical Technologies and its heart implant
Aug 12, 2025